9.5.11.9Vertical

Healthcare & Life Sciences Technology

Software platforms serving hospitals, clinics, payers, pharmacies, and life sciences firms.

27
Sub-verticals

Market snapshot

These figures describe Vertical SaaS (9.5.11), the segment that Healthcare & Life Sciences Technology sits within. They are not figures for Healthcare & Life Sciences Technology on its own.

FragmentationFragmentedEstimate

Not sized separately. One classification covers every software publisher, so it cannot be split between vertical and horizontal products. Vertical software is the more defensible half commercially, because a system built around one industry's workflow faces fewer competitors and far lower churn than a horizontal tool sold to everyone.

Business model & economics

Revenue model

Vertical SaaS subscriptions plus embedded payments/fintech

Key economics

Recurring revenue
High

sticky vertical subscriptions plus payments

EBITDA margin
Strong

deep-workflow, payments-enhanced economics

Capex intensity
Low

Characteristics

  • Industry-specific software (Veeva, Toast, Procore).
  • Embedded payments/fintech raise revenue per customer.
  • One of the most attractive software strategies.

M&A deal context

Deal activityHigh

Who’s acquiring

  • Vertical-SaaS leaders
  • Software PE (vertical roll-ups)
  • VC and growth investors

What’s driving deals

  • Industry digitization and workflow depth.
  • Embedded-payments and fintech monetization.
  • Vertical roll-ups and consolidation.

Sub-verticals in this vertical

Find Healthcare & Life Sciences Technology acquisition targets

Search Acquisera’s index for companies classified under Healthcare & Life Sciences Technology (9.5.11.9) and build a targeted deal pipeline.

Search companies